Analysis of microRNA expression in a HOX-gene based model of acute myeloid leukemia
Kuchenbauer, F.; Rovira, C.; Staaf, J.; Argiropoulos, B.; Piper, J.; Humphries, R.K.
Experimental Hematology (New York) 35(9, Suppl 2): 63
2007
ISSN/ISBN: 0301-472X Accession: 020654229
Full Text Article emailed within 1 workday
Payments are secure & encrypted
Related References
Lim, E.L.; Trinh, D.L.; Ries, R.E.; Wang, J.; Gerbing, R.B.; Ma, Y.; Topham, J.; Hughes, M.; Pleasance, E.; Mungall, A.J.; Moore, R.; Zhao, Y.; Aplenc, R.; Sung, L.; Kolb, E.Anders.; Gamis, A.; Smith, M.; Gerhard, D.S.; Alonzo, T.A.; Meshinchi, S.; Marra, M.A. 2017: MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 35(35): 3964-3977Russ, A.C.; Sander, S.; Lück, S.C.; Lang, K.M.; Bauer, M.; Rücker, F.G.; Kestler, H.A.; Schlenk, R.F.; Döhner, H.; Holzmann, K.; Döhner, K.; Bullinger, L. 2011: Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia Haematologica 96(12): 1783-1791
Said, F.; Tantawy, M.; Sayed, A.; Ahmed, S. 2022: Clinical Significance of MicroRNA-29a and MicroRNA-100 Gene Expression in Pediatric Acute Myeloid Leukemia Journal of Pediatric Hematology/Oncology 44(2): E391-E395
Schwind, S.; Marcucci, G.; Maharry, K.; Radmacher, M.D.; Mrózek, K.; Holland, K.B.; Margeson, D.; Becker, H.; Whitman, S.P.; Wu, Y.-Z.; Metzeler, K.H.; Powell, B.L.; Kolitz, J.E.; Carter, T.H.; Moore, J.O.; Baer, M.R.; Carroll, A.J.; Caligiuri, M.A.; Larson, R.A.; Bloomfield, C.D. 2010: BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study Blood 116(25): 5660-5669
Becker, H.; Maharry, K.; Mrózek, K.; Volinia, S.; Eisfeld, A-Kathrin.; Radmacher, M.D.; Kohlschmidt, J.; Metzeler, K.H.; Schwind, S.; Whitman, S.P.; Mendler, J.H.; Wu, Y-Zhong.; Nicolet, D.; Paschka, P.; Powell, B.L.; Carter, T.H.; Wetzler, M.; Kolitz, J.E.; Carroll, A.J.; Baer, M.R.; Caligiuri, M.A.; Stone, R.M.; Marcucci, G.; Bloomfield, C.D. 2014: Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8 Leukemia 28(8): 1754-1758
Yang, L.; Zhang, H.; Yang, X.; Lu, T.; Ma, S.; Cheng, H.; Yen, K.; Cheng, T. 2021: Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model Frontiers in Oncology 11: 659201
Langer, C.; Marcucci, G.; Holland, K.B.; Radmacher, M.D.; Maharry, K.; Paschka, P.; Whitman, S.P.; Mrózek, K.; Baldus, C.D.; Vij, R.; Powell, B.L.; Carroll, A.J.; Kolitz, J.E.; Caligiuri, M.A.; Larson, R.A.; Bloomfield, C.D. 2009: Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(19): 3198-3204
Marcucci, G.; Maharry, K.; Ruppert, A.S.; Powell, B.L.; Carroll, A.J.; Caligiuri, M.A.; Kolitz, J.E.; Larson, R.A.; Bloomfield, C.D.; Radmacher, M.D.; Mrozek, K.; Vukosavljevic, T.; Paschka, P.; Whitman, S.P.; Langer, C.; Baldus, C.D.; Liu, C.G. 2008: Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features : A Cancer and Leukemia Group B Study Journal of Clinical Oncology 26(31): 5078-5087
Marcucci, G.; Maharry, K.; Radmacher, M.D.; Mrózek, K.; Vukosavljevic, T.; Paschka, P.; Whitman, S.P.; Langer, C.; Baldus, C.D.; Liu, C.-G.; Ruppert, A.S.; Powell, B.L.; Carroll, A.J.; Caligiuri, M.A.; Kolitz, J.E.; Larson, R.A.; Bloomfield, C.D. 2008: Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(31): 5078-5087
Becker, H.; Marcucci, G.; Maharry, K.; Radmacher, M.D.; Mrózek, K.; Margeson, D.; Whitman, S.P.; Wu, Y.-Z.; Schwind, S.; Paschka, P.; Powell, B.L.; Carter, T.H.; Kolitz, J.E.; Wetzler, M.; Carroll, A.J.; Baer, M.R.; Caligiuri, M.A.; Larson, R.A.; Bloomfield, C.D. 2010: Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28(4): 596-604
Metzeler, K.H.; Maharry, K.; Kohlschmidt, J.; Volinia, S.; Mrózek, K.; Becker, H.; Nicolet, D.; Whitman, S.P.; Mendler, J.H.; Schwind, S.; Eisfeld, A-K.; Wu, Y-Z.; Powell, B.L.; Carter, T.H.; Wetzler, M.; Kolitz, J.E.; Baer, M.R.; Carroll, A.J.; Stone, R.M.; Caligiuri, M.A.; Marcucci, G.; Bloomfield, C.D. 2013: A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia Leukemia 27(10): 2023-2031
Xiang, L.; Li, M.; Liu, Y.; Cen, J.; Chen, Z.; Zhen, X.; Xie, X.; Cao, X.; Gu, W. 2013: The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia Annals of Hematology 92(8): 1063-1069
Yan, W.; Xu, L.; Sun, Z.; Lin, Y.; Zhang, W.; Chen, J.; Hu, S.; Shen, B. 2015: MicroRNA biomarker identification for pediatric acute myeloid leukemia based on a novel bioinformatics model Oncotarget 6(28): 26424-26436
Becker, H.; Maharry, K.; Radmacher, M.D.; Mrózek, K.; Metzeler, K.H.; Whitman, S.P.; Schwind, S.; Kohlschmidt, J.; Wu, Y.-Z.; Powell, B.L.; Carter, T.H.; Kolitz, J.E.; Wetzler, M.; Carroll, A.J.; Baer, M.R.; Moore, J.O.; Caligiuri, M.A.; Larson, R.A.; Marcucci, G.; Bloomfield, C.D. 2011: Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study Haematologica 96(10): 1488-1495
Hwang, E.S.; Hong, J.H.; Bae, S.C.; Ito, Y.; Lee, S.K. 1999: Regulation of c-fos gene transcription and myeloid cell differentiation by acute myeloid leukemia 1 and acute myeloid leukemia-MTG8, a chimeric leukemogenic derivative of acute myeloid leukemia 1 FEBS Letters 446(1): 86-90
Whitman, S.P.; Maharry, K.; Radmacher, M.D.; Becker, H.; Mrózek, K.; Margeson, D.; Holland, K.B.; Wu, Y-Zhong.; Schwind, S.; Metzeler, K.H.; Wen, J.; Baer, M.R.; Powell, B.L.; Carter, T.H.; Kolitz, J.E.; Wetzler, M.; Moore, J.O.; Stone, R.M.; Carroll, A.J.; Larson, R.A.; Caligiuri, M.A.; Marcucci, G.; Bloomfield, C.D. 2010: FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study Blood 116(18): 3622-3626
Shivarov, V.; Dolnik, A.; Lang, K.M.; Krönke, J.; Kuchenbauer, F.; Paschka, P.; Gaidzik, V.I.; Döhner, H.; Schlenk, R.F.; Döhner, K.; Bullinger, L. 2016: MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses Haematologica 101(11): E454-E456
Mi, S.; Lu, J.; Sun, M.; Li, Z.; Zhang, H.; Neilly, M.B.; Wang, Y.; Qian, Z.; Jin, J.; Zhang, Y.; Bohlander, S.K.; Le Beau, M.M.; Larson, R.A.; Golub, T.R.; Rowley, J.D.; Chen, J. 2007: MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia Proceedings of the National Academy of Sciences of the United States of America 104(50): 19971-19976
Sarkar, A.; Das, T.; Das, G.; Ghosh, Z. 2023: MicroRNA mediated gene regulatory circuits leads to machine learning based preliminary detection of acute myeloid leukemia Computational Biology and Chemistry 104: 107859
Mendler, J.H.; Maharry, K.; Radmacher, M.D.; Mrózek, K.; Becker, H.; Metzeler, K.H.; Schwind, S.; Whitman, S.P.; Khalife, J.; Kohlschmidt, J.; Nicolet, D.; Powell, B.L.; Carter, T.H.; Wetzler, M.; Moore, J.O.; Kolitz, J.E.; Baer, M.R.; Carroll, A.J.; Larson, R.A.; Caligiuri, M.A.; Marcucci, G.; Bloomfield, C.D. 2012: RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 30(25): 3109-3118